ProductsBack/Human Oxidized LDL ELISA

Human Oxidized LDL ELISA

Name: Human Oxidized LDL ELISA
SKU: 10-1143-01_1X96WELLS_M16
Availability: BackOrder

10-1143-01

Product group Assays

Overview

Supplier
Mercodia
Product Name
Human Oxidized LDL ELISA
Delivery Days Customer
7
Applications
ELISA
Assay Detection Range
1.4 - 19.0 mU/L (9 - 125 U/L when multiplied with dilution factor)
Certification
CE-IVD
Scientific Description
Mercodia Oxidized LDL ELISA kit is intended to be used for in vitro quantification of oxidized low-density lipoproteins (oxidized LDL) in human serum or plasma. Mercodia Oxidized LDL ELISA is a unique sandwich ELISA based on the proprietary mouse monoclonal antibody 4E6, which is directed against a conformational epitope in oxidized ApoB-100. Elevated plasma levels of oxidized LDL are associated with higher cardiovascular risk and higher incidence of metabolic diseases. • CE/IVD labeled on selected markets. • Controls included in the kit. • Accurately measures the physiological signaling on scavenging macrophages that generates foam cells, vascular inflammation, and atherosclerosis.
UNSPSC
41116133

Spoto B, Mattace-Raso F, Sijbrands EJ, et al. Oxidized LDL, Gamma-Glutamyltransferase and Adverse Outcomes in Older Adults. J Am Geriatr Soc. 2017,65(4):e77-e82. doi: 10.1111/jgs.14566
Read this paper
Kaikkonen JE, Kresanov P, Ahotupa M, et al. High serum n6 fatty acid proportion is associated with lowered LDL oxidation and inflammation: the Cardiovascular Risk in Young Finns Study. Free Radic Res. 2014,48(4):420-6. doi: 10.3109/10715762.2014.883071
Read this paper
Lerman RH, Desai A, Lamb JJ, et al. A Phytochemical-rich Multivitamin-multimineral Supplement Is Bioavailable and Reduces Serum Oxidized Low-density Lipoprotein, Myeloperoxidase, and Plasminogen Activator Inhibitor-1 in a Four-week Pilot trial of Healthy Individuals. Glob Adv Health Med. 2014,3(2):34-9. doi: 10.7453/gahmj.2013.098
Read this paper
Verhoeven V, Van der Auwera A, Van Gaal L, et al. Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial. BMC Complement Altern Med. 2015,15:52. doi: 10.1186/s12906-015-0576-9
Read this paper